Through its 2018 acquisition of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio – an important step to keep pace with the rapidly growing biologics market. As a result, Wacker Biotech now has three sites: Jena, Halle and Amsterdam, with a total of about 330 employees. (Photo: Wacker Chemie AG)